首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.
【2h】

Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.

机译:全身性老年淀粉样变性。心脏组织中新的前白蛋白(运甲状腺素蛋白)变异体的鉴定:与一种形式的家族性淀粉样变性多发性神经病的免疫学和生化相似性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Isolated amyloid fibrils from three cases of systemic senile amyloidosis (SSA) contained subunit proteins with molecular masses of 14 (10-20%), 10-12 (60-80%), and 5-6 kD (5-10%) when fractionated under reducing and dissociating conditions. This grouping was identical to that seen in SKO, a case of familial amyloidotic polyneuropathy (FAP) studied earlier. Amino acid sequencing confirmed that SSA subunit proteins were in fact prealbumin (transthyretin). Complete sequence analysis of one SSA preparation revealed the presence of a new variant Pa (TTr) molecule with a single amino acid substitution of isoleucine for valine at position 122. Further studies used an antiserum specific for SKO IV, a subunit protein of SKO previously shown to correspond to carboxy-terminal 78 residues (positions 49-127) of (TTr). Anti-SKO IV reacted with SSA in tissue at equivalent dilutions to anti-Pa (TTr) and with the 10-12-kD fraction of SSA on Western blots; reactivity was blocked by SKO IV, but not by Pa (TTr). SSA is a form of systemic amyloidosis caused by tissue deposition of Pa (TTr) and its fragments, with shared conformational or subunit antigenicity to at least one form of FAP. Identification of a new variant Pa (TTr) molecule in one case suggests further that SSA may be a genetically determined disease expressed late in life.
机译:从三例系统性老年淀粉样变性病(SSA)中分离出的淀粉样原纤维包含亚单位蛋白,其分子质量分别为14(10-20%),10-12(60-80%)和5-6 kD(5-10%)。在还原和离解条件下进行分馏。该分组与SKO中观察到的相同,SKO是较早研究的家族性淀粉样变性多发性神经病(FAP)。氨基酸测序证实,SSA亚基蛋白实际上是前白蛋白(运甲状腺素蛋白)。对一种SSA制剂的完整序列分析表明,在第122位上存在一个新的变体Pa(TTr)分子,该分子具有异亮氨酸的单个氨基酸取代缬氨酸。进一步的研究使用了SKO IV的抗血清特异性,SKO IV是先前显示的SKO亚基蛋白对应于(TTr)的羧基末端78个残基(49-127位)。抗SKO IV与组织中的SSA反应,其稀释度与抗Pa(TTr)相同,并与Western blot上的SSA的10-12-kD部分反应; SKO IV阻止了反应性,但Pa(TTr)则没有。 SSA是由Pa(TTr)及其片段的组织沉积引起的一种全身性淀粉样变性病,对至少一种形式的FAP具有共同的构象或亚基抗原性。在一种情况下,对新变体Pa(TTr)分子的鉴定进一步表明,SSA可能是生命晚期表达的遗传确定的疾病。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号